Antibiotice Iasi (stock symbol: ATB), the largest Romanian owned drug maker, on Friday (June 5) released a report containing new details regarding its international expansion strategy, as it counts on a 25% increase in sales in the United States in 2026, after its main distributor in the US successfully completed ,at the end of May 2026 the audit carried out at the company's production facilities in lasi.